|
Volumn 34, Issue 4, 2008, Pages 353-365
|
Survey of treatment practices for sexual dysfunction(s) associated with anti-depressants
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMANTADINE;
AMFEBUTAMONE;
ANTIDEPRESSANT AGENT;
BETHANECHOL;
BROMOCRIPTINE;
CENTRAL STIMULANT AGENT;
CYPROHEPTADINE;
DEXAMPHETAMINE;
DOPAMINE RECEPTOR STIMULATING AGENT;
EPHEDRINE;
GINKGO BILOBA EXTRACT;
GRANISETRON;
HORMONE;
LORATADINE;
METHYLPHENIDATE;
MIRTAZAPINE;
MODAFINIL;
NEFAZODONE;
NEOSTIGMINE;
PEMOLINE;
PHOSPHODIESTERASE V INHIBITOR;
ROPINIROLE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
SILDENAFIL;
TADALAFIL;
TESTOSTERONE;
TRAZODONE;
VARDENAFIL;
YOHIMBINE;
ARTICLE;
CHOLINERGIC ACTIVITY;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DRUG DOSE REDUCTION;
ERECTILE DYSFUNCTION;
GASTROINTESTINAL SYMPTOM;
HUMAN;
LIBIDO;
LIBIDO DISORDER;
ORGASM;
PSYCHIATRIST;
SEDATION;
SEXUAL DYSFUNCTION;
SIDE EFFECT;
UNSPECIFIED SIDE EFFECT;
ADMINISTRATION, TOPICAL;
ADULT;
ANTIDEPRESSIVE AGENTS;
DEPRESSIVE DISORDER, MAJOR;
FEMALE;
HUMANS;
MALE;
QUESTIONNAIRES;
SEXUAL DYSFUNCTION, PHYSIOLOGICAL;
TESTOSTERONE;
|
EID: 46049102191
PISSN: 0092623X
EISSN: 15210715
Source Type: Journal
DOI: 10.1080/00926230802096390 Document Type: Article |
Times cited : (39)
|
References (9)
|